(Q39176522)

9 September 2017

title

Identifying targets for the restoration and reactivation of BRM. (English)

1 reference

9 September 2017

B Kahali

1

1 reference

9 September 2017

S J B Gramling

2

1 reference

9 September 2017

S B Marquez

3

1 reference

9 September 2017

K Thompson

4

1 reference

9 September 2017

L Lu

5

1 reference

9 September 2017

D Reisman

6

1 reference

9 September 2017

language of work or name

English

0 references

publication date

25 March 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

33

1 reference

9 September 2017

issue

5

1 reference

9 September 2017

page(s)

653-664

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.613

9 September 2017

exact match

0 references

cites work

The SNF/SWI family of global transcriptional activators

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The SWI/SNF complex and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The mammalian SWI/SNF complex and the control of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

When the SWI/SNF complex remodels...the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Diversity and specialization of mammalian SWI/SNF complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

BRG1 contains a conserved domain of the SWI2/SNF2 family necessary for normal mitotic growth and transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

BRG-1 is required for RB-mediated cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Activating AMP-activated protein kinase without AMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

BAF60a interacts with p53 to recruit the SWI/SNF complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Characterization of mammary tumors from Brg1 heterozygous mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Targeted knockout of BRG1 potentiates lung cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

SWI/SNF nucleosome remodellers and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

BRM and BRG1 subunits of the SWI/SNF chromatin remodelling complex are downregulated upon progression of benign skin lesions into invasive tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Growth inhibition by the mammalian SWI-SNF subunit Brm is regulated by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The Brm gene suppressed at the post-transcriptional level in various human cell lines is inducible by transient HDAC inhibitor treatment, which exhibits antioncogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Discovery of BRM Targeted Therapies: Novel Reactivation of an Anti-cancer Gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Maintenance of integrated proviral gene expression requires Brm, a catalytic subunit of SWI/SNF complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Pharmacologic reversal of epigenetic silencing of the anticancer protein BRM: a novel targeted treatment strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

MEF2: a central regulator of diverse developmental programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Histone deacetylase 3 associates with and represses the transcription factor GATA-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Differentiation-specific expression of chromatin remodeling factor BRM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Identification of a core member of the SWI/SNF complex, BAF155/SMARCC1, as a human tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

HER2 as a target for breast cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

EGFR and colon cancer: a clinical view.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Functional interactions between the hBRM/hBRG1 transcriptional activators and the pRB family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Molecular targeted therapy of lung cancer: EGFR mutations and response to EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

ras transformation is associated with decreased expression of the brm/SNF2alpha ATPase from the mammalian SWI-SNF complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

A continuum model for tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Mechanisms of translational deregulation in human tumors and therapeutic intervention strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

New anti-cancer strategies: epigenetic therapies and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

DNA methylation analysis: a powerful new tool for lung cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Histone deacetylase inhibitors and cancer: from cell biology to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Two novel BRM insertion promoter sequence variants are associated with loss of BRM expression and lung cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

HDAC expression and clinical prognosis in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The histone deacetylase 9 gene encodes multiple protein isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Specific activity of class II histone deacetylases in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

GATA Transcription Factors and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Acetylation of GATA-1 is required for chromatin occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Histone deacetylation in epigenetics: an attractive target for anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The MYST family of histone acetyltransferases and their intimate links to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Histone deacetylases and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Acute myeloid leukaemia with 8p11 (MYST3) rearrangement: an integrated cytologic, cytogenetic and molecular study by the groupe francophone de cytogénétique hématologique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

The expression of the SWI/SNF ATPase subunits BRG1 and BRM in normal human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Role of yeast SNF and SWI proteins in transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

Uterine leiomyomata with t(10;17) disrupt the histone acetyltransferase MORF

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

[Her2 a paradigm for targeted therapy].

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.613

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2012.613

1 reference

Dimensions Publication ID

9 September 2017

1018158675

0 references

1 reference